SAUDI-MINISTRY-TOURISM
The Saudi Ministry of Tourism is participating in the 46th Annual NYU International Hospitality Investment Conference, highlighting the Kingdom's exceptional progress and vast investment opportunities within its booming tourism sector. This conference presents a unique platform for Saudi Arabia to share its transformative journey towards becoming a premier global tourism destination while diversifying its economy.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240606244256/en/
Saudi Ministry of Tourism Deputy Minister for Tourism Destination Enablement Mahmoud Abdulhadi Speaking at the "Invest Saudi & Prosper in Tourism" Networking Lunch (Photo: AETOSWire)
At the forefront of the conference, Mahmoud Abdulhadi, Deputy Minister of Tourism Destination Enablement, delivered a keynote speech to the attendees. He discussed the abundant opportunities in Saudi Arabia, providing insights on investing in tourism to develop new destinations. Mahmoud emphasized how international investors can benefit from the opportunities created, underlining the Kingdom’s commitment to becoming a leading global tourism destination.
Complementing the keynote, the "Invest Saudi & Prosper in Tourism" Networking Lunch, hosted by the Ministry of Tourism, offered a deep dive into Saudi Arabia's investment potential under Vision 2030. The event featured speakers from the Saudi Ministry of Tourism and Ministry of Investment, focusing on the transformation and development in the market, sector performance, and investment opportunities. The government’s support for investors through the Tourism Investment Enablers Program (TIEP), which focuses on enhancing the ease and cost of doing business in the tourism sector, provides incentives, and opens up this untapped market, was also discussed in detail.
The TIEP is designed to lower investment barriers, reduce government fees by 22%, and offer significant incentives. The program includes the flagship Hospitality Investment Enablers (HIE) initiative, which aims to generate USD 11.2 billion in private-sector investments and create 120,000 jobs in identified tourism destinations with high potential. These initiatives make Saudi Arabia an attractive and lucrative destination for investors.
Mahmoud Abdulhadi, Deputy Minister of Tourism Destination Enablement, said, "Saudi Arabia stands at the threshold of an unprecedented transformation in its tourism sector, offering unparalleled opportunities for investors. Our commitment to Vision 2030 is not just a blueprint for development; it's an open invitation for global partners to be part of a historic journey. By investing in Saudi Arabia, you are investing in a future where innovation, culture, and hospitality converge to create extraordinary experiences. The Tourism Investment Enablers Program and the Hospitality Investment Enablers initiative are designed to provide you with the support, incentives, and reduced barriers needed to succeed in this thriving market. Together, we can build a world-class tourism destination that benefits not only our economy but also the global community."
As part of the Ministry of Tourism’s participation at the event, Gloria Guevara Manzo, Chief Special Advisor at the Ministry of Tourism, Saudi Arabia, took part in a fireside chat titled "The Travel and Tourism Trends Driving the Market." The session examined the trends that hospitality investors and other stakeholders need to consider to drive their strategies, providing valuable insights into the evolving landscape of global tourism.
This discussion underscored Saudi Arabia’s significant strides in its tourism sector, notably attracting 100 million international visitors in 2023, seven years ahead of schedule. This success sets the stage for the Kingdom’s new target of 150 million tourists, reflecting its growing global appeal.
Further highlighting its success, Saudi Arabia rose nine places to 41st in the World Economic Forum's Travel & Tourism Development Index 2024, demonstrating the impact of its strategic investments and robust regulatory framework. Recognized as one of the safest countries to visit in the Middle East, the Kingdom’s appeal to international investors continues to grow.
With an investment of USD 800 billion into its tourism sector, Saudi Arabia is creating 1.6 million job opportunities and adding 500,000 hotel rooms. These investments are driving the Kingdom’s economic and social transformation, focusing on developing cultural sites, sports venues, theme parks, and nature reserves. Additionally, the Ministry of Tourism’s efforts to simplify the e-visa process for 66 countries further boost tourism inflows and investment opportunities, making the Kingdom more accessible to international visitors.
*Source: AETOSWire
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240606244256/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Biocytogen and Acepodia Expand Collaboration Through Option-based Evaluation Framework for First-in-Class Bispecific and Dual-Payload ADCs (BsAD2C)9.1.2026 13:00:00 CET | Press release
Expanded collaboration builds on Acepodia and Biocytogen’s recent co-development efforts to evaluate selected bispecific antibody and dual-payload ADC programs Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315) and Acepodia (6976:TT), today announced that the companies have entered into an option and license agreement designed to enable the structured evaluation of bispecific antibody-drug conjugate (BsADC) programs to further advance the development of dual-payload bispecific antibody-drug conjugates (BsAD2Cs). The agreement grants Acepodia an option to obtain an exclusive worldwide license from Biocytogen for two BsADC programs. Under the terms of the agreement, Biocytogen is eligible to receive an upfront option fee and, upon Acepodia’s exercise of the option, additional payments including option exercise fees, development, regulatory, and commercial milestone payments, as well as royalties on future product sales. The financial terms of the agreem
Blockstream Capital Partners Announces Strategic Acquisition of Derivatives Trading Team from Numeus Group, Leveraging Strategic Partnership with Komainu9.1.2026 11:08:00 CET | Press release
Blockstream Capital Partners (“BCP”) today announced that it has entered into a strategic agreement to acquire a division within Numeus Group’s digital asset trading and investment business. The transaction includes the absorption of select Bitcoin focused trading strategies with a focus on yield generation as well as a ten person derivatives trading team led by Chief Investment Officer Deepak Gulati, a specialist in volatility and derivatives markets. Deepak Gulati, appointed Co-Chief Investment Officer of Blockstream Capital Management alongside Rodrigo Rodriguez, previously served as Global Head of Proprietary Trading at JPMorgan, before founding Argentiere Capital, a multibillion-dollar volatility-focused hedge fund. With a thesis that derivatives would drive Bitcoin and digital asset market maturity, he co-founded Numeus Group in 2021 to develop institutional-grade trading, risk management and market-structure capabilities. Komainu, an existing BCP strategic investment, has played
Autel Unveils Strategic Shift at CES 2026: Building the AI-Powered Infrastructure of Future Cities9.1.2026 10:44:00 CET | Press release
At the Consumer Electronics Show (CES), Autel Energy is presenting its latest AI-driven smart hardware and software systems for the future of intelligent urban operations. This year’s showcase highlights Autel’s shift from AI concept validation to scenario-based engineering deployment, emphasizing closed-loop execution across real-world infrastructure. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260101511436/en/ Autel Energy New Product Debut at CES 2026 Focusing on two key domains — Smart Energy and Smart Inspection — the company is unveiling a range of new products. In Smart Energy, Autel is introducing V2G (Vehicle-to-Grid) AC charger for homes and DC charging solution for fleets, strengthening its multi-tier energy touchpoint strategy from households to commercial operations. Live demonstrations at the booth will feature a smart charging robot showcasing automated plug-in capabilities. In Smart Inspection, Autel will
Allianz and Anthropic Forge Global Partnership to Advance Responsible AI in Insurance9.1.2026 10:00:00 CET | Press release
Anthropic’s safety-first AI meets Allianz's dedication to customer centricity, stakeholder trust, and regulatory excellenceThree focus areas of the partnership: workforce empowerment, operations automation through agentic AI, and regulatory compliance Allianz SE and Anthropic today announced a global partnership to accelerate the adoption of responsible Artificial Intelligence (AI) at Allianz. The collaboration centers on three transformative projects within Allianz Group designed to empower Allianz employees and accelerate operations, while setting new benchmarks for accuracy. “With this partnership, Allianz is taking a decisive step to address critical AI challenges in insurance. Anthropic’s focus on safety and transparency complements our strong dedication to customer excellence and stakeholder trust. Together, we are building solutions that prioritize what matters most to our customers while setting new standards for innovation and resilience,” said Oliver Bäte, CEO of Allianz SE.
MRM Health Secures FDA IND Clearance to Launch its Phase 2b Trial of MH002 in Mild-to-Moderate Ulcerative Colitis9.1.2026 07:00:00 CET | Press release
MH002 is currently the most advanced Live Biotherapeutic Product (LBP) based on a rationally-designed combination of disease specific bacteria (microbial consortia), for the treatment of inflammatory bowel diseases (IBD) STARFISH-UC Phase 2b trial is designed to confirm MH002’s early efficacy signals and favorable safety observed in Phase 2a studies MRM Health NV, a clinical-stage biopharmaceutical company pioneering microbiome-based therapeutics for inflammatory diseases and immune-oncology, today announced that the U.S. Food and Drug Administration (FDA) has granted clearance of its Investigational New Drug (IND) application for its lead program MH002. This enables the initiation of the STARFISH-UC Phase 2b clinical trial in patients with mild-to-moderate ulcerative colitis, marking a significant step forward in the development of next-generation therapies for inflammatory bowel diseases (IBD). About the STARFISH-UC Phase 2b Trial The STARFISH-UC trial is a randomized, double-blind,
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
